| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 250, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
5.74 |
1.15 |
6.89 |
7% |
0.4 |
6.14 |
1.23 |
7.37 |
20% |
1.15 |
7.29 |
1.46 |
8.75 |
|
НСР-8019/08.02.2016.; НСР-12588/05.05.2017 |
24.02.2016 |
02.06.2017 |
Заличен |
1412 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 250, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
5.74 |
1.15 |
6.89 |
7% |
0.4 |
6.14 |
1.23 |
7.37 |
20% |
1.15 |
7.29 |
1.46 |
8.75 |
|
НСР-8019/08.02.2016. |
24.02.2016 |
24.02.2016 |
Неактивен |
1412 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 500, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
11.48 |
2.3 |
13.78 |
6% |
0.69 |
12.17 |
2.43 |
14.6 |
18% |
2.07 |
14.24 |
2.85 |
17.09 |
|
НСР-8018/08.02.2016. |
24.02.2016 |
24.02.2016 |
Неактивен |
1413 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 1000, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
22.96 |
4.59 |
27.55 |
6% |
1.38 |
24.34 |
4.87 |
29.21 |
18% |
4.13 |
28.47 |
5.69 |
34.16 |
|
НСР-8017/08.02.2016. |
24.02.2016 |
24.02.2016 |
Неактивен |
1414 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 1000, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
59.18 |
11.84 |
71.02 |
4% |
2.37 |
61.55 |
12.31 |
73.86 |
16% |
9.47 |
71.02 |
14.2 |
85.22 |
|
КЦРР-1518/18.10.2012 |
02.11.2012 |
02.11.2012 |
Неактивен |
1414 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 250, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
20.81 |
4.16 |
24.97 |
6% |
1.25 |
22.06 |
4.41 |
26.47 |
18% |
3.75 |
25.81 |
5.16 |
30.97 |
|
КЦРР-1518/18.10.2012 |
02.11.2012 |
02.11.2012 |
Неактивен |
1412 |
| Levetiracetam |
20120111 |
Repitend, Film coated tablet, 500, mg, Pack: 30 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Pharmaceutical Works Polpharma S.A. , Poland |
41.58 |
8.32 |
49.9 |
4% |
1.66 |
43.24 |
8.65 |
51.89 |
16% |
6.65 |
49.89 |
9.98 |
59.87 |
|
КЦРР-1518/18.10.2012 |
02.11.2012 |
02.11.2012 |
Неактивен |
1413 |
| Levetiracetam |
20120115 |
Repitend, Oral solution, 100 mg/ml - 300 ml, mg, Pack: 1 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Medana Pharma S.A., Poland |
57.21 |
11.44 |
68.65 |
4% |
2.29 |
59.5 |
11.9 |
71.4 |
16% |
9.15 |
68.65 |
13.73 |
82.38 |
корекц. Решение НСР-9826/21.07.2016 |
КЦРР-1517/18.10.2012 |
02.11.2012 |
02.09.2016 |
Активен |
1411 |
| Levetiracetam |
20120115 |
Repitend, Oral solution, 100 mg/ml - 300 ml, mg, Pack: 1 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Medana Pharma S.A., Poland |
57.21 |
11.44 |
68.65 |
4% |
2.29 |
59.5 |
11.9 |
71.4 |
16% |
9.15 |
68.65 |
13.73 |
82.38 |
корекц. Решение НСР-9826/21.07.2016 |
КЦРР-1517/18.10.2012 |
02.11.2012 |
02.09.2016 |
Неактивен |
1411 |
| Levetiracetam |
20120111 |
Repitend, Oral solution, 100 mg/ml - 300 ml, mg, Pack: 1 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
Medana Pharma S.A., Poland |
57.21 |
11.44 |
68.65 |
4% |
2.29 |
59.5 |
11.9 |
71.4 |
16% |
9.15 |
68.65 |
13.73 |
82.38 |
|
КЦРР-1517/18.10.2012 |
02.11.2012 |
02.11.2012 |
Неактивен |
1411 |
| Agalsidase alfa |
EU/1/01/189/002 |
Replagal, Concentrate for solution for infusion, 1 mg/ml - 3.5 ml, mg, Pack: 4 |
Shire Human Genetic Therapies AB, Швеция |
Shire Human Genetic Therapies AB, Швеция |
10212.8 |
2042.56 |
12255.36 |
4% |
10 |
10222.8 |
2044.56 |
12267.36 |
16% |
25 |
10247.8 |
2049.56 |
12297.36 |
Оставена без разглеждане жалба от Комисия по прозрачност КП-111/03.12.2014 |
НСР-3768/13.06.2014; НСР-13264/20.07.2017 |
04.08.2017 |
02.09.2017 |
Активен |
3416 |
| Agalsidase alfa |
EU/1/01/189/002 |
Replagal, Concentrate for solution for infusion, 1 mg/ml - 3.5 ml, mg, Pack: 4 |
Shire Human Genetic Therapies AB, Швеция |
Shire Human Genetic Therapies AB, Швеция |
10212.8 |
2042.56 |
12255.36 |
4% |
10 |
10222.8 |
2044.56 |
12267.36 |
16% |
25 |
10247.8 |
2049.56 |
12297.36 |
Оставена без разглеждане жалба от Комисия по прозрачност КП-111/03.12.2014 |
НСР-3768/13.06.2014; НСР-13264/20.07.2017 |
04.08.2017 |
02.09.2017 |
Неактивен |
3416 |
| Agalsidase alfa |
EU/1/01/189/002 |
Replagal, Concentrate for solution for infusion, 1 mg/ml - 3.5 ml, mg, Pack: 4 |
Shire Human Genetic Therapies AB, Швеция |
Shire Human Genetic Therapies AB, Швеция |
10212.8 |
2042.56 |
12255.36 |
4% |
10 |
10222.8 |
2044.56 |
12267.36 |
16% |
25 |
10247.8 |
2049.56 |
12297.36 |
Оставена без разглеждане жалба от Комисия по прозрачност КП-111/03.12.2014 |
НСР-3768/13.06.2014; НСР-13264/20.07.2017 |
04.08.2017 |
02.09.2017 |
Неактивен |
3416 |
| Agalsidase alfa |
EU/1/01/189/002 |
Replagal, Concentrate for solution for infusion, 1 mg/ml - 3.5 ml, mg, Pack: 4 |
Shire Human Genetic Therapies AB, Швеция |
Shire Human Genetic Therapies AB, Швеция |
14343.41 |
2868.68 |
17212.09 |
4% |
10 |
14353.41 |
2870.68 |
17224.09 |
16% |
25 |
14378.41 |
2875.68 |
17254.09 |
Оставена без разглеждане жалба от Комисия по прозрачност КП-111/03.12.2014 |
НСР-3768/13.06.2014 |
16.12.2014 |
16.12.2014 |
Неактивен |
3416 |
| Goserelin |
20150379 |
Reseligo, implant in pre-filled syringe, 3.6, mg, Pack: 1 |
Alvogen IPCo S.àr.l, Люксембург |
AMW GmbH Arzneimittelwerk Warngau, Birkerfeld 11, Warngau, 83627, Германия |
64.91 |
12.98 |
77.89 |
4% |
2.6 |
67.51 |
13.5 |
81.01 |
16% |
10.39 |
77.9 |
15.58 |
93.48 |
|
НСР-8086/12.02.2016.; НСР-10904/11.11.2016 (допуска предварително изпълнение) |
11.11.2016 |
02.12.2016 |
Активен |
4188 |
| Goserelin |
20150379 |
Reseligo, implant in pre-filled syringe, 3.6, mg, Pack: 1 |
Alvogen IPCo S.àr.l, Люксембург |
AMW GmbH Arzneimittelwerk Warngau, Birkerfeld 11, Warngau, 83627, Германия |
64.91 |
12.98 |
77.89 |
4% |
2.6 |
67.51 |
13.5 |
81.01 |
16% |
10.39 |
77.9 |
15.58 |
93.48 |
|
НСР-8086/12.02.2016.; НСР-10904/11.11.2016 (допуска предварително изпълнение) |
11.11.2016 |
02.12.2016 |
Неактивен |
4188 |
| Goserelin |
20150378 |
Reseligo, implant in pre-filled syringe, 10.8, mg, Pack: 1 |
Alvogen IPCo S.àr.l, Люксембург |
AMW GmbH Arzneimittelwerk Warngau, Birkerfeld 11, Warngau, 83627, Германия |
194.72 |
38.94 |
233.66 |
4% |
7.79 |
202.51 |
40.5 |
243.01 |
16% |
25 |
227.51 |
45.5 |
273.01 |
|
НСР-8086/12.02.2016.; НСР-10903/11.11.2016 (допуска предварително изпълнение) |
11.11.2016 |
02.12.2016 |
Активен |
4189 |
| Goserelin |
20150378 |
Reseligo, implant in pre-filled syringe, 10.8, mg, Pack: 1 |
Alvogen IPCo S.àr.l, Люксембург |
AMW GmbH Arzneimittelwerk Warngau, Birkerfeld 11, Warngau, 83627, Германия |
194.72 |
38.94 |
233.66 |
4% |
7.79 |
202.51 |
40.5 |
243.01 |
16% |
25 |
227.51 |
45.5 |
273.01 |
|
НСР-8086/12.02.2016.; НСР-10903/11.11.2016 (допуска предварително изпълнение) |
11.11.2016 |
02.12.2016 |
Неактивен |
4189 |
| Goserelin |
20150379 |
Reseligo, implant in pre-filled syringe, 3.6, mg, Pack: 1 |
Alvogen IPCo S.àr.l, Люксембург |
AMW GmbH Arzneimittelwerk Warngau, Birkerfeld 11, Warngau, 83627, Германия |
90.03 |
18.01 |
108.04 |
4% |
3.6 |
93.63 |
18.73 |
112.36 |
16% |
14.4 |
108.03 |
21.61 |
129.64 |
|
НСР-8086/12.02.2016. |
27.02.2016 |
27.02.2016 |
Неактивен |
4188 |
| Goserelin |
20150378 |
Reseligo, implant in pre-filled syringe, 10.8, mg, Pack: 1 |
Alvogen IPCo S.àr.l, Люксембург |
AMW GmbH Arzneimittelwerk Warngau, Birkerfeld 11, Warngau, 83627, Германия |
303.23 |
60.65 |
363.88 |
4% |
10 |
313.23 |
62.65 |
375.88 |
16% |
25 |
338.23 |
67.65 |
405.88 |
|
НСР-8086/12.02.2016. |
27.02.2016 |
27.02.2016 |
Неактивен |
4189 |
| Quetiapine |
ІІ-10668/08.09.2010 |
RESIRENTIN, Film coated tablet, 200, mg, Pack: 60 |
V12 Kft,, Унгария |
Cemelog-BRS KFT, 2040 Budaors, Vasut u.13., Унгария Genepharm SA, 18km Marathon Avenue, 15351 Pallini, Гърция |
15.41 |
3.08 |
18.49 |
6% |
0.92 |
16.33 |
3.27 |
19.6 |
18% |
2.77 |
19.1 |
3.82 |
22.92 |
цената се заличава с решение НСР-7136/24.09.2015 (в сила от 13.10.2015) |
НСР-7003/24.08.2015. |
12.09.2015 |
12.09.2015 |
Заличен |
2959 |
| Quetiapine |
ІІ-10666/08.09.2010 |
RESIRENTIN, Film coated tablet, 100, mg, Pack: 60 |
V12 Kft,, Унгария |
Cemelog-BRS KFT, 2040 Budaors, Vasut u.13., Унгария; Genepharm SA, 18km Marathon Avenue, 15351 Pallini, Гърция |
7.04 |
1.41 |
8.45 |
7% |
0.49 |
7.53 |
1.51 |
9.04 |
20% |
1.41 |
8.94 |
1.79 |
10.73 |
цената се заличава с решение НСР-7136/24.09.2015 (в сила от 13.10.2015) |
НСР-6319/28.05.2015. |
15.06.2015 |
15.06.2015 |
Заличен |
2638 |
| Quetiapine |
ІІ-10668/08.09.2010 |
RESIRENTIN, Film coated tablet, 200, mg, Pack: 60 |
V12 Kft,, Унгария |
Cemelog-BRS KFT, 2040 Budaors, Vasut u.13., Унгария Genepharm SA, 18km Marathon Avenue, 15351 Pallini, Гърция |
22.71 |
4.54 |
27.25 |
6% |
1.36 |
24.07 |
4.81 |
28.88 |
18% |
4.09 |
28.16 |
5.63 |
33.79 |
|
НСР-3716/06.06.2014 |
04.07.2014 |
04.07.2014 |
Неактивен |
2959 |
| Quetiapine |
ІІ-10666/08.09.2010 |
RESIRENTIN, Film coated tablet, 100, mg, Pack: 60 |
V12 Kft,, Унгария |
Cemelog-BRS KFT, 2040 Budaors, Vasut u.13., Унгария; Genepharm SA, 18km Marathon Avenue, 15351 Pallini, Гърция |
16.02 |
3.2 |
19.22 |
6% |
0.96 |
16.98 |
3.4 |
20.38 |
18% |
2.88 |
19.86 |
3.97 |
23.83 |
|
НСР-2360/21.01.2014 |
01.04.2014 |
01.04.2014 |
Неактивен |
2638 |
| Quetiapine |
ІІ-10668/08.09.2010 |
RESIRENTIN, Film coated tablet, 200, mg, Pack: 60 |
V12 Kft,, Унгария |
Cemelog-BRS KFT, 2040 Budaors, Vasut u.13., Унгария Genepharm SA, 18km Marathon Avenue, 15351 Pallini, Гърция |
30.51 |
6.1 |
36.61 |
4% |
1.22 |
31.73 |
6.35 |
38.08 |
16% |
4.88 |
36.61 |
7.32 |
43.93 |
|
КЦРР-2387/21.02.2013 |
04.04.2013 |
04.04.2013 |
Неактивен |
2959 |